Acorda Therapeutics (ACOR) to Present at the JMP Healthcare Conference
7/3/2013 7:07:53 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Andrew R. Blight, Ph.D., Acorda’s Chief Scientific Officer, and Tierney Saccavino, Senior Vice President, Corporate Communications, will present at the JMP Healthcare Conference on Wednesday, July 10 at 11:30 a.m. at the St. Regis Hotel in New York.
Help employers find you! Check out all the jobs and post your resume.